A consortium, consisting of Valitacell, Solentim and Microcoat, has been awarded €2.5million under the highly competitive H2020 Fast Track to Innovation (FTI) initiative, and a further €1million from other sources Solentim and Valitacell announce a total of €3.5m funding to produce an integrated platform to deposit, culture, profile and select optimal cells for the manufacture of life-saving biological medicines. Building […]

Two private investors and High-Tech Gründerfonds (HTGF) are convinced of the importance of single-cell isolation for the production of biopharmaceuticals and for genetic analysis in research and diagnostics. EUR 3 million will be invested in the further development of the technology, the expansion of the sales organization and in opening up further applications for Cytena’s […]

CytoSMART Omni – The world’s smallest live-cell imager Eindhoven, The Netherlands – CytoSMART, the Eindhoven-based company that develops and manufactures digital microscopes for monitoring live cell cultures, has received 5.2 million Euros to fund the growth of their business. New investor Eindhoven Venture Capital Fund II joined existing investors Holland Capital and BOM Brabant Ventures. […]

CytoSMART Omni – The world’s smallest live-cell imager Eindhoven, The Netherlands – CytoSMART, the Eindhoven-based company that develops and manufactures digital microscopes for monitoring live cell cultures, has received 5.2 million Euros to fund the growth of their business. New investor Eindhoven Venture Capital Fund II joined existing investors Holland Capital and BOM Brabant Ventures. […]

LAVAL, QUEBEC, CANADA – March 25, 2019 – Prometic Life Sciences Inc. (TSX:PLI, OTCQX: PFSCF) (“Prometic” or the “Corporation”) announced today that it has secured an additional USD $5 million (CAD $6.7 million) tranche fromStructured Alpha LP (“SALP”), an affiliate of Thomvest Asset Management Inc., under the existing loan agreement originally entered into with SALP […]

Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners Lawrence, MA — Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, announced today that it has received a strategic investment from Ampersand Capital Partners.  The funding will be primarily used to support Nexcelom’s worldwide growth initiatives. […]

Ovation.io, a next-generation clinical informatics company, today announced Series A funding of $5 million led by Madrona Venture Group with participation from new investors Borealis Ventures, Nat Turner, Zach Weinberg, and existing investors StagedotO and David Shaw. Ovation.io provides operations and intelligence software for next-generation precision diagnostic labs. Ovation will use the funding to accelerate lab deployment […]

NEW YORK — Gencove, the leading low-pass genome sequencing platform, announced today a $3 million investment led by Spero Ventures. Alexandria Venture Investments and Burst Capital participated in the round, along with existing investors Third Kind Venture Capital and Version One Ventures. The funding will be used to develop new applications for agricultural markets as well as expand Gencove’s […]

Othram wins a research grant from Illumina Accelerator and presents at SXSW on breakthrough sequencing and informatics techniques for reconstructing genomes from challenging DNA samples.  THE WOODLANDS, TEXAS Othram, Inc. was awarded a research sequencing grant from Illumina Accelerator after presenting at SXSW for the “Digitizing Biology Through Genomics” session as part of the Energizing […]